Samuels SL, Chajecki A, Hu P, Kayser M, et al. Real-world use of glucagon-like peptide-1 receptor agonists in youth with type 2 diabetes is associated with short-term improvements in HbA1c. Diabetes Obes Metab 2024 Jan 16. doi: 10.1111/dom.15430.
PMID: 38229444